Regenxbio Inc (NASDAQ:RGNX)

22.57
Delayed Data
As of Oct 04
 -1.57 / -6.50%
Today’s Change
18.69
Today|||52-Week Range
40.59
-30.98%
Year-to-Date
No recent news for Regenxbio Inc.

Today’s Trading

Previous close24.17
Today’s open24.33
Day’s range22.16 - 26.32
Volume801,373
Average volume (3 months)391,314
Market cap$1.1B
Data as of 4:00pm ET, 10/04/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-288.98%
Earnings growth (next 5 years)+11.81%
Revenue growth (last year)+204.30%
P/E ratio10.7
Price/Sales3.05
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
AUPHAurinia Pharmaceutic...+0.10+1.35%
EBSEmergent BioSolution...+0.05+0.23%
RCKTRocket Pharmaceutica...+1.72+11.10%
IMGNImmunoGen Inc+0.51+10.52%
Data as of 4:00pm ET, 10/04/2022

Financials

Next reporting dateNovember 9, 2022
EPS forecast (this quarter)-$1.47
Annual revenue (last year)$470.3M
Annual profit (last year)$127.8M
Net profit margin27.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Rockville, Maryland

Forecasts